Literature DB >> 25275077

A prospective case-control study on the impact of neoadjuvant chemotherapy on surgery-related outcomes of laparoscopic radical hysterectomy.

Giorgio Bogani1, Antonella Cromi2, Maurizio Serati2, Edoardo Di Naro3, Jvan Casarin2, Nicola Marconi2, Davide Sturla2, Nicoletta Donadello2, Fabio Ghezzi2.   

Abstract

AIM: To investigate whether perioperative outcomes of class III/type C laparoscopic radical hysterectomy (LRH) for cervical cancer (CC) are influenced by neoadjuvant chemotherapy (NACT). PATIENTS AND METHODS: Data of consecutive patients, affected by locally advanced-stage CC, undergoing NACT plus LRH were matched 1:2 with consecutive patients, affected by early-stage CC who underwent LRH without NACT.
RESULTS: Twenty and 40 patients underwent NACT with LRH and LRH aIone, respectively. Demographic characteristics were balanced between groups. Number of lymph nodes yielded, parametrial width and length of vaginal cuff were not influenced by preoperative administration of NACT. Patients undergoing NACT plus LRH experienced slightly higher blood loss (225 vs. 200 ml; p=0.05) than patients in the control group, but had a similar operative time and length of hospital stay. No between-group differences in transfusion and complications rates were observed (p>0.2).
CONCLUSION: The administration of NACT does not affect the surgery-related outcomes of LRH. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cervical cancer; laparoscopy; neoadjuvant chemotherapy; radical hysterectomy; uterine cervix

Mesh:

Year:  2014        PMID: 25275077

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis.

Authors:  Hui Zhao; Yue He; Shu-Li Yang; Qun Zhao; Yu-Mei Wu
Journal:  Onco Targets Ther       Date:  2019-03-07       Impact factor: 4.147

2.  Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery.

Authors:  Haiying Sun; Kecheng Huang; Fangxu Tang; Xiong Li; Xiaoli Wang; Sixiang Long; Shasha Zhou; Jianwei Zhang; Ruoqi Ning; Shuang Li; Shixuan Wang; Ding Ma
Journal:  Sci Rep       Date:  2018-04-24       Impact factor: 4.379

3.  MR-Based Radiomics Nomogram of Cervical Cancer in Prediction of the Lymph-Vascular Space Invasion preoperatively.

Authors:  Zhicong Li; Hailin Li; Shiyu Wang; Di Dong; Fangfang Yin; An Chen; Siwen Wang; Guangming Zhao; Mengjie Fang; Jie Tian; Sufang Wu; Han Wang
Journal:  J Magn Reson Imaging       Date:  2018-10-26       Impact factor: 4.813

4.  Effect of neoadjuvant chemotherapy followed by surgery for FIGO stage I-II cervical cancer: a meta-analysis.

Authors:  Shu-Li Yang; Ling Chen; Yue He; Hui Zhao; Yu-Mei Wu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.